These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 29248133)
21. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation. Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149 [TBL] [Abstract][Full Text] [Related]
22. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses. Kim Y; Choi JW; Lee JH; Kim YS Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395 [TBL] [Abstract][Full Text] [Related]
23. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4. Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345 [TBL] [Abstract][Full Text] [Related]
24. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis. Sheng G; Gao Y; Wu H; Liu Y; Yang Y J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318 [TBL] [Abstract][Full Text] [Related]